
Armoda150 mg
ACI Limited
Armodafinil is a wakefulness-promoting agent (the R-enantiomer of modafinil) used to improve wakefulness in adults with excessive sleepiness.
Armodafinil is a wakefulness-promoting agent (the R-enantiomer of modafinil) used to improve wakefulness in adults with excessive sleepiness. Its established (FDA-approved) indications are:
Armodafinil is sometimes used off-label for other causes of excessive sleepiness or fatigue (e.g., in certain psychiatric or neurological conditions); such use is not FDA-approved and should only be undertaken under specialist supervision.
| Indication | Recommended Dose |
|---|---|
| Narcolepsy | 150 mg to 250 mg once daily in the morning |
| Obstructive sleep apnea (adjunct to primary therapy, e.g., CPAP) | 150 mg to 250 mg once daily in the morning |
| Shift work disorder | 150 mg once daily, taken approximately 1 hour before the start of the work shift |
In patients with severe hepatic impairment, the dose of Armodafinil should be reduced (e.g., to approximately half the usual recommended dose), as drug clearance is significantly decreased.
No specific dose adjustment is established for renal impairment, though caution is advised in severe renal disease.
Not established; safety and efficacy of Armodafinil have not been established in patients under 17 years of age (see Use in Special Populations).
Armodafinil tablets may be taken with or without food. Consistency in the time of day (morning, or before a shift for shift work disorder) helps maintain wakefulness when it is needed.
The most common side effects of Armodafinil include:
Armodafinil is contraindicated in:
No other absolute contraindications are established; cardiovascular, psychiatric, and dermatologic concerns are addressed under Precautions and Warnings and require clinical judgment rather than automatic exclusion from use.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.